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Low protein diet blunts the rise in glomerular gene expression
in focal glomeruloscierosis
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and HIKARU K0IDE
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Low protein diet blunts the rise In glomerular gene expression in focal
glomeruloscierosis. The present study was designed to assess whether
expression of mRNA for extracellular matrix (ECM) components,
metalloproteinases (MMP) and tissue inhibitor of metalloproteinases
(TIMP) in glomeruli is affected by a low protein diet during the course
of focal glomeruloscierosis (FGS). Puromycin aminonucleoside (PAN)
was injected intraperitoneally in rats and the right kidney was removed
on day 22. Nephrotic rats received successive intraperitoneal injections
of PAN on days 27, 34, and 41. Control rats were subjected to a
nephrectomy or a sham operation on day 22. Animals were divided into
six groups. In group 1, the PAN-injected rats were fed a standard diet
containing 22% protein. In group 2, the PAN-injected rats were fed a
low protein diet containing 6% protein, starting on the same day as the
first PAN injection. In group 3, the nephrectomized rats without PAN
were fed a standard diet. In group 4, the nephrectomized rats without
PAN were fed a low protein diet for the same period. In group 5, the
sham operated rats were fed a standard diet. In group 6, the sham
operated rats were fed a low protein diet for the same period. Rats were
sacrificed on days 0, 60 or 80 after the initial PAN or saline injection.
The percentage of sclerotic glomeruli in group I rats increased mark-
edly with time, reaching 77% on day 80. The mRNA levels encoding for
al(I), al(III), al(IV) collagen chains, laminin BI and B2 chains,
heparan sulfate proteoglycan (HSPG), MMP-2, TIMP-l and TIMP-2
increased significantly as glomeruloscierosis progressed, whereas
MMP-l and MMP-3 mRNA levels were unchanged, and no MMP-9
mRNA was detected throughout the experiments. In group 2, the low
protein diet reduced the prevalence of glomerulosclerosis and attenu-
ated the increased mRNA expression for ECM components, MMP-2,
TIMP-l and TIMP-2 in FGS glomeruli. In groups 3 through 6, mRNA
levels for ECM components decreased with age, whereas those for
MMPs and TIMPs changed little throughout the experiments. Immu-
nofluorescence studies revealed the accumulation of types I, III and IV
collagens, laminin, and HSPG in the sclerotic area and low protein diet
attenuated the accumulation of these proteins. These data suggest that
glomeruloscierosis may result from an imbalance among ECM compo-
nents, MMPs and TIMPs and that a low protein diet attenuates the
otherwise increased levels of mRNA for ECM components, MMP-2,
TIMP-1 and TIMP-2 in glomerulosclerosis.
Many renal diseases progress to end-stage renal failure with
glomeruloscierosis independent of the initial pathogenetic
mechanism [1]. Puromycin aminonucleoside (PAN) nephrosis is
an experimental model of nephrotic syndrome that progresses
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to focal glomerulosclerosis (FGS) [2, 3]. However, the precise
mechanism that leads to the glomeruloscierosis is still un-
known. Mesangial cell proliferation is a central feature in many
renal diseases and has been associated with the subsequent
development of glomerulosclerosis, leading finally to progres-
sive renal failure [4]. As extracellular matrix (ECM) production
seems to be under the control of growth factors, the glomerular
lesion may well lead to the activation and release of growth
factors, which would produce an excessive accumulation of
ECM, thus causing the glomerulosclerosis [5]. Many investiga-
tors have reported that abnormal production of ECM compo-
nents was associated with the progression of glomerulosclerosis
[6—10]. It is suggested that the development of glomeruloscie-
rosis is, at least in part, the result of increased ECM production,
regulated at the transcriptional level [10]. We reported previ-
ously that mRNA levels for ECM components in glomeruli of
PAN-induced FGS rats increase as glomeruloscierosis
progresses [11]. However, glomerulosclerosis is not only a
consequence of ECM overproduction by glomerular cells but
also appears to involve other processes [12]. The balance
between the local production of ECM-degrading proteases,
including metalloproteinases (MMP)- 1, -2, -3, and -9, and tissue
inhibitor of metalloproteinase (TIMP)-1 and -2 may play a
crucial role in determining the degree of sclerosis and the
ultimate fate of the glomerulus [13]. At a molecular level, ECM
accumulation is the net result of the balance between the
synthesis of ECM components and the degradation of these
molecules, that correlates with the relative synthesis of MMPs
and TIMPs [14]. Some investigators have demonstrated that
cultured mesangial cells express MMP-2 [15], MMP-3 and
TIMP mRNA [161. The synthesis of MMPs is regulated at the
transcriptional level. However, it remains unknown how ex-
pression of genes for MMPs and TIMPs may be regulated in
glomeruli in PAN-induced FGS.
It has been demonstrated in numerous models of experimen-
tal renal injury, including PAN nephrosis, that long-term di-
etary protein restriction reduces proteinuria and ameliorates
progressive structural damage [17—24]. Protein restriction sig-
nificantly normalized hemodynamic derangements in the gb-
merular microcirculation that developed after renal ablation
[17]. Several mechanisms may explain the alteration in afferent
arteriolar vasoconstriction produced by a low-protein diet.
They include an effect on glomerular eicosanoid metabolism,
specifically, a reduction in prostaglandin E2 and thromboxane
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Table 1. Amount of food ingested (g) and body weight (g) on days 0,
60 and 80 in groups 1 and 2
Days
0 60 80
Group 1 15 3/184 10 21 6/260 22 26 8/320 40
Group 2 15 4/188 14 18 4/220 16 19 6/240 36
Values are expressed as means SD.
B2 [25]. Isolated glomeruli from rats on the low-protein diet
exhibited a significantly diminished response to administered
agonist [25]. Another potential site for dietary protein restric-
tion to affect glomerular function is the permselectivity barrier
itself [25]. We reported previously that changes in growth factor
mRNA levels in glomeruli may contribute to the development
of PAN-induced FGS [26] and that a low protein diet attenuates
increases in the expression of genes for PDGF and TGF-/3 in
this model [27]. In the present study, we examined whether a
low protein diet affects the levels of mRNA for glomerular ECM
components, MMPs and TIMPs in the FGS model.
Methods
Animals
Male Sprague-Dawley rats weighing 150 to 200 grams were
used for this study. The method used to produce FGS in rats
was described previously by Glasser, Velosa and Michael [2].
Briefly, puromycin aminonucleoside (PAN; Sigma Chemical
Co., St. Louis, Missouri, USA) was injected intraperitoneally
(15 mg/l00 g body wt) in 100 rats from which the right kidney
was removed on day 22. The nephrectomized rats again re-
ceived intraperitoneal injections of PAN (5 mg/l00 g body wt)
on days 27, 34, and 41. One hundred control rats received saline
injection on days 0, 27, 34, and 41 and were subjected to a
nephrectomy (50 rats) or a sham operation (50 rats) on day 22.
All animals were divided into six groups. In group 1, the PAN
injected rats were fed a standard diet containing 22% protein. In
group 2, the PAN injected rats were fed a low protein diet
containing 6% protein, starting on the same day as the first PAN
injection [27]. In group 3, the nephrectomized rats without PAN
injection were fed a standard diet. In group 4, the nephrecto-
mized rats without PAN were fed a low protein diet for the
same period. In group 5, the sham operated rats were fed a
standard diet. In group 6, the sham operated rats were fed a low
protein diet for the same period. Eight rats each in groups were
sacrificed on days 0, 60, or 80 after the initial PAN injection or
saline injection. The protein used was casein and both diets
were isocaloric (352 KcalIlOO g). They contained the same
amount of fat (5.2%), calcium (0.86%), phosphorus (0.7%),
magnesium (0.2%), trace elements (1.0%) and vitamin mix
(1.0%) [27]. The 22% diet consisted of 54.6% carbohydrate and
5.7% cellulose, while the 6% diet contained 70.5% carbohydrate
and 5.7% cellulose. To maintain the same calorie, mineral, and
electrolyte intake per gram of body weight in each group, the
diet was adjusted every two weeks in proportion to body weight
[18, 22]. Amount of food ingested and body weight on days 0, 60
and 80 in groups 1 and 2 was shown in Table 1. Urinary protein
excretion was determined by the Coomassie Brilliant Blue-G
250 method using a commercial standard (Tonein TP Kit;
Ohtsuka Pharmacy, Tokyo, Japan) [26—28].
Morphological assessment
Kidneys were fixed in 10% neutral buffered formalin, and
coronal slices were embedded in paraffin for light microscopy.
Sections 2 m thick were stained with hematoxylin and eosin
(HE) and periodic acid-Schiff reagent (PAS). Glomerulosclero-
sis was defined as loss of cellular elements from the glomerular
capillary tuft, collapse of capillary lumina, and folding of the
glomerular capillary wall with entrapment of amorphous mate-
rial. A semiquantitative score was used to evaluate the degree
of glomerular sclerosis according to the method previously
described [29—31]. One hundred glomeruli were examined inde-
pendently and the severity of each lesion was graded from 0 to
4+ where: a I + lesion represented involvement of 25% of the
glomerulus; 2+, 25 to 50%; 3+, 50 to 75%; and 4+, 75 to 100%.
An injury score (glomerulosclerosis index) was then obtained
by multiplying the degree of damage (0 to 4+) by the percentage
of the glomeruli having the same degree of glomeruloscierosis.
Immunofluorescence staining of renal tissues was performed
by the method previously described [7, 32]. Rabbit antibodies to
mouse laminin, collagen IV and heparan sulfate proteoglycan
(HSPG), prepared as described previously [33—35] (1:16), were
provided by Dr. Yoshihiko Yamada (National Institute of
Dental Research, Bethesda, Maryland, USA). Monoclonal an-
tibody for rat collagens I and III were provided by Dr. Akira
Ooshima (Wakayama Medical College, Wakayama, Japan) (1:
16) [36]. Fluorescein isothiocyanate (FITC)-conjugated goat
anti-rabbit IgG was purchased from Cappel Laboratories (Mat-
vern, Pennsylvania, USA). Renal sections (4 m) were incu-
bated with various antibodies after the second incubation with
FITC-conjugated anti-rabbit IgG antibodies. To evaluate Types
I, III, and IV collagen, laminin and HSPG staining, each
glomerulus was graded semiquantitatively [4, 8] where: 0 indi-
cated diffuse, very weak or absent mesangial matrix staining
and no localized increase of staining; 1+, diffuse, weak mesan-
gial matrix staining with Ito 25% of the glomerular tuft showing
focally increased staining; 2+, 25 to 50% of the glomerular tuft
demonstrating focal, strong staining; 3+, 50 to 75% of the
glomerular tuft staining strongly in a focal manner; 4+, more
than 75% of the glomerular tuft staining strongly. Thirty gb-
merular cross sections containing more than 20 discrete capil-
lary segments were evaluated by an observer, who was un-
aware of the origin of the slides. The accumulation of ECM
proteins within the tubulointerstitium was also assessed semi-
quantitatively by fluorescence microscopy. At least 50 random
fields contained within a 10 mm x 10 mm eyepiece grid were
each assigned an arbitrary intensity score from 1 to 3, where 1
represented a normal scoring pattern; 2, slightly increased ECM
protein staining; and 3, markedly increased staining [37]. For
sampling consistency, the immunohistochemical studies were
performed on the cortical interstitium.
Isolation of glomeruli
The glomeruli were isolated by sieving through 75, 106, and
125 sm meshes [28]. Each glomerular preparation used was
more than 90% pure and contained very few tubular fragments.
The glomerular yield was determined by examining 100 1.d of
each sample. The isolated glomeruli were centrifuged, fixed
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Fig. 1. Urinary protein excretion in the six
groups of rats described in the Methods.
Symbols are: (0) group 1; (•) group 2; (Lx)
group 3; (A) group 4; (0) group 5; (U) group30 40 50 60 70 80 6. Values are expressed as means SD. *P <
0.05, **P < 0.01, < 0.001, group I
Time, days versus group 2.
with formalin and then embedded in paraffin. The sections were
cut, stained with periodic acid-Schiff and assessed by light
microscopy. Previous studies revealed that the prevalence of
sclerotic glomeruli in the sieved glomeruli reflected accurately
that seen in tissue sections [11, 27, 38].
Preparation of glomerular RNA and Northern analysis
Total cellular RNA was extracted from isolated glomeruli
from three separate groups of eight rats each by the acid
guanidinium thiocyanate-phenol chloroform extraction method
[39]. The total RNA concentration was determined spectropho-
tometrically at 260 nm and 280 nm. RNA samples (15 tg/1ane)
were denatured and electrophoresed through 0.7% agarose gels
containing 2.2 M formaldehyde and then transferred by capillary
blotting onto nylon filters (Gene Screen, New England Nuclear,
Boston, Massachusetts, USA). Before transferring the RNA
onto the nylon membrane, the ethidium-stained gels were
visualized under ultraviolet illumination to determine the posi-
tion of the 28S and 18S ribosomal RNA bands, assess the
integrity of RNA and verify that equal amounts of RNA were
loaded. RNA was fixed to the nylon filters by ultraviolet
irradiation for five minutes at 254 nm. The cDNA probes used
for Northern analysis were as follows, Clones for the aI(IV)
collagen chain (pFAC), laminin Bl (p24) and B2 (p7) chains
were isolated from a cDNA library constructed from differen-
tiated F9 teratocarcinoma cell mRNA, as reported previously
[35, 40]. Heparan sulfate proteoglycan (clone 7), rat aI(I)
(paIRI) and al(III) (1.8 kb EcoRl fragment) collagen eDNA
probes were provided by Dr. Yoshihiko Yamada [41—43]. Rat
MMP- 1 and MMP-3 cDNA probes were provided by Dr. Lynn
M. Matrisian (Vanderbilt University, Nashville, Tennessee,
USA) [44, 45]. cDNA probes for human type IV collagenase
72KD (MMP-2) and 92KD (MMP-9) were provided by Drs.
Gregory I. Goldberg and Barry L. Marmer (Washington Uni-
versity School of Medicine, St. Louis, Missouri, USA) [46, 47].
Human TIMP-1 cDNA was provided by Dr. Masanobu Naruto
(Basic Research Laboratories, Toray Industries, Kanagawa,
Japan) [48]. Rat GAPDH cDNA and human TIMP-2 eDNA
were obtained from the American Type Culture Collection
(Rockville, Maryland, USA). All probes were labeled with
[a-32P]-deoxycytidine 5-triphosphate (3000 Cilmmol) by ran-
dom primer extension [49]. Hybridization was carried out in 1%
bovine serum albumin (BSA), 7% sodium dodecyl sulfate
(SDS), 0.5 M NaH2PO4, 1 m ethylenediamine tetraacetic acid
(EDTA) and 100 g/ml sonicated salmon sperm DNA for 20
hours at 65°C [50]. The filters were washed three times in 0.5%
BSA, 5% SDS, 40 mrvi NaH2PO4 and 1 m'vi EDTA at 65°C, and
then three times in 1% SDS, 40 mss NaH2PO4 and 1 mrvt EDTA
at 65°C [50]. After drying, filters were exposed to Kodak
X-OMAT-AR film (Eastman Kodak, Rochester, New York,
USA) with enhancing screens at —70°C. The resulting autora-
diograms were read by linear densitometry (Shimadzu CS-9000
densitometer, Shimadzu Manufacturing, Kyoto, Japan). The
filters were stripped in 0.01 x SSPE (1 x SSPE = 0.18 M NaC1,
0.01 M NaH2PO4, 0.001 M EDTA), 0.5% SDS for 30 minutes at
95°C prior to rehybridization.
Quantitation of mRNA
All Northern analyses were repeated three times with gb-
merular RNA preparations obtained from different sets of
animals [4]. Fixation, hybridization and washing conditions
were identical to those used for Northern analysis. Densitom-
etry reading was normalized for equivalent amounts of GAPDH
per lane. Values are expressed as optical density units relative
to the specific mRNA level observed in glomerular RNA from
sham operated rats with 22% protein diet (Group 5).
Statistical analysis
All values are expressed as means SD. Statistical signifi-
cance was determined by Student's t-test or one way analysis of
variance.
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Fig. 2. Periodic acid-Schijjstained glomeruli
from a group I on days 60 (A) and 80 (B)
after the initial PAN injection. Glomeruli
show marked mesangial expansion and
mesangial cell proliferation with collapse of
capillary lumens. The 6% protein diet
ameliorated the histopathological changes on
days 60 (C) and 80 (D) after initial PAN
injection. x200
Results
Urinary protein excretion
In group 1, rats developed proteinuria within four days after
the initial injection of PAN. Proteinuria was maximum on day 8
(180 36 mg/day) and then declined. Significant proteinuria
again developed on day 48 (430 58 mg/day) following right
nephrectomy and the second series of PAN injections and then
declined gradually with days. In group 2, urinary protein
excretion was suppressed markedly by the 6% protein diet (Fig.
1). In groups 3 to 6, urinary protein excretion remained approx-
imately 40 mg/day throughout the experimental period (80
days).
Light microscopy
The prevalence of glomerular sclerosis in groups 1 to 6 at
various time points is shown in Table 1. In group 1, the
percentage of glomerular sclerosis in rats increased significantly
with time and reached to 76.8 11.4% on day 80. Numerous
areas of segmental mesangial expansion and hypercellularity
developed with time (Fig. 2a, b). In addition, tubular PAS-
positive casts were seen frequently, and in the most severely
affected kidneys, there was focal tubular atrophy with mono-
cytic infiltration that disrupted occasionally the tubular base-
ment membrane. In group 2, the 6% protein diet attenuated the
prevalence of glomerular sclerosis and only 14.2 5.6% of the
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6 Fig. 3. Glomerulosclerosis index (means
standard error) (A) on day 60 and (B) on day
80. *D < 0.01 and ** < 0.001.
Fig. 4. Immunofluorescent microscopy of the
glomerulus on day 80. Rabbit antibody to
mouse type IV collagen (x400) in (A) Group 1
and (B) group 2. Immunofluorescence for type
IV collagen is significantly increased in
sclerotic area in group I. The 6% low protein
diet ameliorates the increase in staining of
type IV collagen.
glomeruli were sclerotic on day 80. On days 60 and 80, as shown
in Figure 2c and d, mesangial expansion and mesangial cell
proliferation were also significantly lower in group 2 than in
group 1. The sclerosis indices (SI) on days 60 (A), and 80 (B)
were significantly higher in group 1 than in group 2 (day 60, 186
36 vs. 18 5 and on day 80, 276 64 vs. 34 9, P < 0.01;
Fig. 3). In groups 3 to 6, the percentage of glomerular sclerosis
in rats was very low (Table 2).
Immunohistochemistry
On day 0, type IV collagen, laminin, and HSPG showed a
similar staining pattern. These proteins were localized in the
mesangium, glomerular basement membrane, and tubular base-
ment membrane. Type I and III collagens were stained in the
interstitium but not in the glomeruli. However, as glomerulo-
Table 2. Incidence of glomerulosclerosis
Groups
Days
60 80
1 39.8 16.6 76.8 11.4
2 7.8 2.8 14.2 5.6
3 2.1 0.8 4.6 1.8
4 1.6 0.6 2.8 1.2
5 2.2 0.9 2.6 1.0
6 1.8 0.8 2.2 0.8
Values are given in percentages as mean SD.
sclerosis developed with time, both the basement membrane
components and type I and III collagens accumulated in the
sclerotic areas in group 1 (Fig. 4; type IV collagen and Fig. 5;
**
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Fig. 5. Immunofluorescent microscopy of the
glomerulus on day 80. Rabbit antibody to rat
type I (A, group 1 and B, group 2) and III (C,
group 1 and D, group 2) collagens (X400). The
sclerotic area contains large amounts of type I
collagen in group 1. The 6% protein diet
ameliorated the increase in staining for type I
collagen.
type I and III collagen). In group 2, 6% protein diet attenuated
the increase in staining for type I, III, and IV collagens, laminin
and HSPG in the sclerotic areas (Figs. 4 and 5). Figure 6 shows
the glomerular immunohistochemical staining scores observed
for type IV collagen (A), laminin (B), and HSPG (C) in groups
1 to 6 on days 60 (left side) and 80 (right side). Figure 7 shows
the same scores observed for type I collagen (A) and III
collagens (B) as well. Figure 8 shows the interstitial scores for
type IV collagen (A), laminin (B), and HSPG (C). Figure 9
shows the interstitial scores for type I collagen (A) and III
collagens (B). Increased quantities of ECM components were
present in the tubulointerstitium on day 60 and were further
increased on day 80 in group 1. In group 2, 6% protein diet
attenuated the increase in staining for ECM components in the
tubulointerstitium.
Glomerular gene expression for type I, III, and IV collagens,
laminin Bi and B2 chains and HSPG
The results of the Northern blots of mRNA encoding for the
al(I), al(III), and al(IV) collagen chains, the Bi and B2 chains
of laminin, the core protein of HSPG, and GAPDH in group I
are shown in Figure 10. Table 3 shows the relative changes of
mRNA for these proteins in groups ito 6 on days 60 and 80. In
glomeruli obtained from groups 3 to 6, the steady state levels of
mRNA for these proteins decreased over time, as previously
reported [11, 28, 51]. A different expression pattern was ob-
served in glomeruli from rats in group 1. The ai(IV) transcripts
increased 5.2-fold by day 60 (P < 0.01) and 8.4-fold by day 80
(P < 0.01) as compared to age-matched sham operated rats on
a 22% protein diet (group 5). Laminin B 1 and B2 chain and
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Fig. 6. Glomerular immunohistochemical staining scores observed for
type IV collagen (A), laminin (B), and HSPG (C) in groups 1 to 6 on
days 60 and 80 after the initial PAN injection. Group 1 versus Group 2,
*P < 0.01, and ** < 0.001; N = 8. Symbols are: (E) day 60 and ()
day 80.
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Fig. 7. Glomerular immunohistochemical staining scores observed for
type I collagen (A) and type III collagen (B) in groups 1 to 6 on days 60
and 80 after the initial PAN injection, Group I versus Group 2, *P <
0.01, < 0.001; N = 8. Symbols are: (0) day 60 and ()day 80.
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HSPG mRNAs showed a similar expression pattern [On day 60,
laminin Bi, 4.3-fold (P < 0.01); laminin B2, 4.6-fold (P < 0.01);
HSPG, 3.6-fold (P < 0.05) and on day 80, laminin Bl, 7.8-fold
(P < 0.01); laminin B2, 8.3-fold (P < 0.01);and HSPG, 9.0-fold
(P < 0.01)]. The mRNA levels for al(I) and al(III) collagen
chains increased in a way similar to al(IV) collagen chain,
laminin chains and HSPG [On day 60, al(I), 6.8-fold (P < 0.01);
al(III), 4.2-fold (P < 0.01); and on day 80, al(I), 12.2-fold (P <
0.001); and al(III), 7.4-fold (P < 0.01)]. mRNA levels for
GAPDH showed little change in all groups.
Glomerular expression of genes for MMPs and TIMPs
mRNA levels for MMPs and TIMPs showed a different
expression pattern. Figure 11 shows Northern blots of mRNA
for MMP- 1, -2, and -3, TIMP-1 and TIMP-2 in glomeruli of
group 1. Table 4 shows the relative changes of mRNA for these
proteins in groups I through 6 on days 60 and 80. mRNA levels
for MMP-1, -2 and -3, TIMP-l and TIMP-2 in glomeruli in
groups 3 through 6 showed little change throughout the exper-
imental period. mRNA levels for MMP-1 and -3 in glomeruli in
group 1 also showed little change throughout the experimental
period, whereas those for MMP-2, TIMP-1 and TIMP-2 in-
creased as the glomerular sclerosis progressed [on day 60,
MMP-2, 2.6-fold (P < 0.05); TIMP-1, 4.6-fold (P < 0.01);
TIMP-2, 3.8-fold (P < 0.01); and on day 80, MMP-2, 4.8-fold
(P < 0.01); TIMP-1, 9.6-fold (P < 0.001); and TIMP-2, 8.6-fold
(P < 0.001)]. In contrast, MMP-9 mRNA was not detected in
glomeruli of any group throughout the experiment.
Effect of low protein diet on glomerular expression of genes
for ECM components, MMPs and TIMPs
Figure 12 shows the Northern blot analysis of mRNA for
ECM components including al(I), al(III), and al(IV) collagen
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1 [I [• [' and renal failure [2, 11, 26, 37]. However, the pathogenesis of
___________________________________________
glomeruloscierosis is still unknown. Overactivity of growth-
1 2 3 4 5 6 promoting factors which stimulate ECM production may serve
to link glomerular hypertrophy with subsequent sclerosis [4, 52,
Groups 53]. We have reported previously that mRNA levels for growth
Fig. 8. Interstitial immunohistochemical staining scores observed for factors in glomeruli of FGS rats increased as the glomeruloscie-
lype IV collagen (A), laminin (B) and HSPG (C) in groups ito 6 on days rosis progressed [26]. The composition of the sclerotic matrix in
60 and 80 after the initial PAN injection. Group I versus group 2, *P < glomeruloscierosis has been studied extensively by immunoflu-0.01, and ** <0.001;N = 8. Symbols are: (0) day 60 and () day 80. orescence [6, 9, 54, 55] and a corresponding increase in the
ECM component mRNA levels has been shown in isolated
glomeruli from several animal models [8, 10, 56]. We reported
chains, laminin Bi and B2 chains, HSPG, MMP-l, -2, -3, previously that ECM proteins and mRNA levels in glomeruli of
TIMP-l and -2 in glomeruli in groups 1 and 2 on day 80. The low PAN-induced FGS increase as glomerular sclerosis progresses
protein diet attenuated the increased mRNA levels for ECM [11]. In the present study, we demonstrated that mRNA levels
components including al(I), al(III), and al(IV) collagen for MMP-2, TIMP-l and TIMP-2 in glomeruli of FGS rats also
chains, laminin BI and B2 chains and HSPG as it did for increased with age, whereas those for MMP-1 and MMP-3
MMP-2, TIMP-1 and TIMP-2 in the glomeruli of FGS rats in showed little change throughout the experimental period. Re-
group 2 (Tables 3 and 4). The low protein diet did not affect cently, Carome et al [57] demonstrated that TIMP-1 and
mRNA levels for ECM components, MMPs, and TIMPs in the TIMP-2 genes were expressed in normal human glomeruli in
glomeruli of rats in groups 4 and 6. vivo and that their expression levels were increased in patients
with glomeruloscierosis. Increased proteolysis by secreted
Discussion ECM proteases has been implicated under a number of patho-
The PAN-treated unilateral nephrectomized rat provides a logic conditions characterized by intense ECM metabolism
well characterized model of glomerular sclerosis and interstitial [46]. However, in vivo expression of MMPs and their associa-
fibrosis that results in the development of massive proteinuria tions with pathological conditions is poorly understood. While
Fig. 10. Northern blot analysis of total
glomerular RNA (15 pUg/lane) obtained in
group 1 rats on days 0, 60, and 80 for the
expression of al(I) (A), al(III) (B) and al(IV)
collagen chains (C), laminin BI (D) and B2
chains (E), HSPG (F), and GAPDH (G). One
representative experiment is shown. N = 3.
Lane I: day 0, lane 2: day 60, lane 3: day 80.
Fig. 11. Northern blot analysis of glomerular
RNA for MMP-l (A), MMP-2 (B), MMP-3
(C), TIMP-1 (D) and TIMP-2 (E) in group 1
rats on days 0, 60, and 80. N = 3. Lane 1:
day 0, lane 2: day 60, lane 3: day 80.
Table 3. Glomerular gene expression of al(I), aI(III), al(IV) collagen chains, laminin B! and B2 chains, heparan sulfate proteoglycan
(HSPG) in groups 1 to 6
Day 60 Day 80
laminin laminin laminin laminin
Group al(I) al(III) al(IV) Bl B2 HSPG al(I) al(III) aI(IV) Bl B2 HSPG
1 6.8 20b 4.2 l.8a 5.2 22b 43 2.Oa 4.6 2.0 3.6 l.4a 12.2 4.2C 7.4 28b 8.4 28b 7.8 22b 8.3 21b 9.0 2.6C
2 2.4±0.9 1.8±0.9 2.0±0.9 1.8±0.9 2.2±1.2 1.6±0.8 3.4±1.6 2.6±1.6 3.0±1.8 2.8±1.0 2.6±1.0 2.8±1.2
3 1.2 0.4 1.4 1.0 1.3 0.6 1.4 0.8 1.3 0.4 1.4 0.6 1.4 0.8 1.6 0.8 1.6 0.4 1.7 0.6 1.5 0.7 1.6 0.4
4 1.0±0.4 1.2±0.6 1.1±0.5 1.2±0.6 1.2±0.6 1.4±0.6 1.1±0.5 1.3±0.4 1.3±0.5 1.3±0.5 1.2±0.4 1.4±0.3
5 1 1 1 1 1 1 1 1 1 1 1 I
6 0.8±0.4 1.2±0.3 0.9±0.4 0.8±0.5 1.0±0.4 0.9±0.6 0.9±0.5 1.1±0.6 1.2±0.6 1.1±0.5 0.9±0.4 0.8±0.4
Results are given as densitometry readings compared to that observed with glomerular RNA from group 5 rats. Prior to this all reading were
normalized for equivalent amounts of GAPDH mRNA.
a p < 0.05, b p < 0.01, C P <0.001 group 1 vs. group 2.
many in vitro studies have found coordinate stimulation of
MMPs and TIMPs in response to cytokines or growth factors
[58—60], disparate regulation has been observed for glucocorti-
coids [61], TGF-/3 [59], and interferon [62], suggesting that
MMPs and TIMPs are not always produced concomitantly [63].
We reported previously that enhanced expression of mRNA for
MMP and TIMP may contribute to the evolution of glomerular
injury in lupus nephritis and may be involved in the extensive
ECM remodeling that accompanies lupus nephntis [64]. In
addition, we demonstrated that glomerular mRNA levels for
MMP- 1 and MMP-3 decreased with age in diabetic rats and that
those for TIMP-l increased significantly [65]. Kitamura et al
[16] demonstrated that increased matrix production and re-
pressed matrix degradation via both up-regulated TIMP and
downregulated MMP play important roles in the accumulation
of mesangial matrix in diabetic nephropathy. In the present
study, we demonstrated that mRNA for MMPs and TIMPs are
not coordinately expressed in FGS glomeruli. Although MMP-2
and MMP-3 are capable of degrading components of the base-
ment membrane, the synthesis of MMP-3 in normal connective
tissue is almost negligible, whereas MMP-2 is expressed con-
stitutively in cultured connective tissue cells [46, 66]. Some
investigators reported that TIMP production may be enhanced
upon their stimulation by cytokines, including IL-6 [67] and
TGF-3 [68]. In the glomeruli of FGS rats, these cytokines may
stimulate TIMP mRNA expression. Recently, Lovett et al [13]
demonstrated that enhanced expression of 72 kDa type IV
collagenase may contribute to the evolution of glomerular
injury in immune complex-mediated glomerulonephritis. IL-l
significantly stimulates the secretion of mesangial type IV
collagenase [69]. The pattern of enhanced type IV collagenase
expression observed in our model may be the result of aug-
mented cytokine release. We previously reported that certain
growth factors including TGF-f3 and PDGF have been ex-
pressed at increased levels in FGS [26]. Therefore, such growth
factors may enhance MMP-2 mRNA in FGS. Enhanced MMP-2
ctl(I) al(III)
Nakamura et al: Effect of low protein diet in glomeruloscierosis 1601
al(IV)123 123 123
—5.7kb
•4_4.7kb • S •-6.Okb $ .-7.2kb
— 5.4kb
B C
Laminin BI Laminin B2 HSPG GAPDI-I123 123 123 123
.- 7.0kb 8.0kb • e— 12kb • Ø+—l.3kb
E G
MMP-1 MMP-2 MMP-3 TIMP-1 TIMP-2
123 123 123 123 123
•
.2.skb—
_l_3.lkblJfl+l.9kb — 0+1.0kb
4 +1.Okt
B D E
Fig. 12. Northern blot analysis of glomerular
RNA for aI(I) (A), al(IlI) (B), aI(IV)
fi .3kb collagen chains (C), laminin Bi (D) and B2
chains (E), HSPG (F), MMP-1 (C), MMP-2
(H), MMP-3 (I), TJMP-1 (J), TIMP-2 (K) and
GAPDH (L) in groups 1 and 2 on day 80.
N = 3. Lane 1: group 1, lane 2: group 2.
Table 4. Glomerular gene expression of MMP-1, MMP-2, MMP-3, TIMP-l and TIMP-2 in groups I to 6
Day 60 Day 80
Group MMP-1 MMP-2 MMP-3 TIMP-1 TIMP-2 MMP-1 MMP-2 MMP-3 TIMP-1 TIMP-2
1 1.3 0.3 2.6 0.8a 1.4 0.4 4.6 13b 3.8 11b 1.3 0.4 4.8 13b 1.5 0.2 9.6 2.8c 8.6 2.8c
2 1.2±0.4 1.4±0.6 1.3±0.2 1.9±0.8 1.8±1.0 1.3±0.3 2.0±0.9 1.4±0.4 2.4±1.0 2.6±1.2
3 1.3±0.4 1.2±0.4 1.3±0.3 1.4±0.4 1.3±0.3 1.3±0.4 1.4±0.2 1.3±0.2 1.4±0.3 1.5±0.4
4 1.2 0,3 1.1 0.2 1.3 0.2 1.4 0.2 1.3 0.4 1.1 0.2 1.3 0.4 1.2 0.3 1.1 0.2 1.4 0.3
5 1 1 1 1 1 1 1 1 1 1
6 0.9 0.3 0.8 0.3 0.9 0.4 1.1 0.3 1.2 0.4 1.1 0.2 1.2 0.4 0.8 0.3 0.9 0.4 0.8 0.2
Results are given as densitometry readings compared to that observed with glomerular RNA from group 5 rats. Prior to this all reading were
normalized for equivalent amounts of GAPDH mRNA.
a p <0.05, b p < P < 0.01 group 1 vs. group 2
expression may be an important factor in the remodeling of the
excess matrix that accumulates in FGS. The general expression
pattern of the al(IV) collagen chain mRNA was similar to that
of MMP-2 [70], and laminin B 1 chain and MMP-2 may be
somehow connected in vivo [71]. The cellular activation of
MMP-2/TIMP-2 complex differs from that demonstrated for
MMP-l [72]. We demonstrated that mRNA levels for ECM
components, MMP-2 and TIMP-2 are coordinately regulated in
glomeruli of FGS. It is postulated that the expression of MMP-9
is associated with cellular migration, invasion, and tissue ca-
tabolism under certain pathological conditions. MMP-9 was
originally thought to be restricted to neutrophils and macro-
phages [73, 74]. We could not detect MMP-9 mRNA expression
in the glomeruli of any group during the experimental period.
Jones et al [37] revealed by Northern blot analysis a marked
increase in TIMP mRNA levels and no change in MMP- 1 and
MMP-3 mRNA levels in the renal cortex of chronic PAN-
treated rats. These data are consistent with our studies of
glomerular RNA. Modulation of the balance between MMPs
and TIMPs is one potentially important mechanism by which
TGF-f3 enhances accumulation of ECM following tissue injury
[75]. The data suggest that the net ECM protein accumulation
observed in FGS was due to a combination of increased ECM
synthesis and relatively decreased ECM degradation caused by
an increase in TIMPs.
Many investigators have demonstrated the efficacy of dietary
protein restriction in various experimental models of glomerular
injury that progress to FGS. Diamond and Karnovsky [22] have
demonstrated that the renal functional and histologic abnormal-
ities of chronic PAN nephrosis can be ameliorated significantly
by a low protein diet. They showed that a low protein diet is
accompanied by significant reductions in glomerular filtration
rate and renal plasma flow and that these hemodynamic alter-
ations were associated favorably with lower urinary protein
excretion and amelioration of renal pathology, including nota-
ble mesangial cell proliferation and glomerular sclerosis. Okuda
et a! [23] demonstrated that a low protein diet ameliorates the
experimental glomerulonephritis induced by intravenous injec-
tion of anti-thymocyte antiserum by suppressing TGF-/3 expres-
sion and preventing the induction of ECM synthesis in injured
glomeruli. We reported previously that a low protein diet
suppresses TGF-f3 and PDGF mRNA expression in glomeruli of
PAN-induced FGS rats [27]. In the present study, a low protein
diet prevented the enhancement of ECM synthesis in the
glomeruli of PAN-induced FGS rats. Suppression of glomerular
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matrix build up by a low protein diet was accompanied by a
significant parallel reduction in proteinuria, an important clini-
cal indicator of glomerular injury. The precise mechanisms by
which dietary protein restriction affects ECM component ex-
pression are unknown. It was reported that prostaglandins
stimulate the proliferation of smooth muscle cells [76]. The
alterations in renal eicosanoid metabolism may directly partic-
ipate in the pathogenesis of glomerulosclerosis and thus provide
a rationale for therapy directed toward the specific inhibition of
thromboxane in the treatment of glomeruloscierosis [77]. A low
protein diet may inhibit the synthesis of prostaglandins, inhibit
the proliferation of smooth muscle cells like mesangial cells,
and suppress ECM synthesis. We previously reported that ET- I
mRNA levels increased in glomeruli of FGS rats [78]. ET
increased expression of mRNA for ECM components by cul-
tured mesangial cells [79]. We recognized that a low protein diet
attenuates increased ET-l mRNA levels in FGS glomeruli
(Nakamura T et a!, unpublished data). Therefore, a low protein
diet may inhibit ET-l synthesis and suppress ECM synthesis.
However, the exact mechanism by which a low protein diet
would suppress glomerular sclerosis remains unclear. Nitric
oxide is synthesized from L-arginine by a specific biochemical
pathway found in a variety of cells and involving every organ
system. Nitric oxide is an effector molecule in inflammatory and
immunological tissue injury. Recently, Noble et a! [80] demon-
strated that L-arginine supplementation to the low protein diet
abolished the beneficial effects of the low protein diet and that
L-arginine is a key substrate in the beneficial effects of low
protein diet. Therefore, in vivo products of L-arginine may be
directly or indirectly linked to the progression of FGS.
In summary, we demonstrated that dietary protein restriction
ameliorates histopathological changes and increased gloinerular
ECM component, MMP-2, TIMP-l and TIMP-2 mRNA expres-
sion. These data indicate that therapeutic effect may be by
reducing growth factor gene expression that would otherwise
increase in the gained synthesis of ECM components, MMP-2,
and TIMP mRNA in the glomeruli of FGS rats.
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